相关实验视频

Updated: Jan 13, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

I型干扰素β在膀癌细胞中诱导强烈的抗瘤反应

Marlena Hesse¹, Max Iltzsche¹, Daniel Nahhas¹

¹Department of Urology, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Fetscherstr. 74, 01307, Dresden, Germany.

Journal of cancer research and clinical oncology

|January 8, 2026

概括

干扰素 (IFN) 暴露会激活膀癌细胞,显示出抗增殖和免疫调节作用. 这项研究阐明了IFN,特别是IFN-β如何影响膀癌细胞,为癌症治疗提供了先天免疫系统激活的见解.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
细胞生物学细胞生物学

背景情况:

非肌肉侵入性膀癌 (NMIBC) 用菌卡尔梅特-盖林 (BCG) 治疗,该药物通过不清楚的机制激活先天免疫系统.
了解膀癌细胞如何对干扰素 (IFN) 等免疫调节剂做出反应,对于改善疗法至关重要.

研究的目的:

研究不同类型的干扰素 (IFN) 激活膀癌 (BLCA) 细胞.
阐明JAK/STAT通路和干扰素刺激基因 (ISG) 在BLCA中IFN介导细胞反应中的作用.

主要方法:

用IFN-α2,IFN-β和IFN-λ1.1激发BLCA细胞系 (RT4,SW780) 的刺激.
定量PCR (qPCR) 用于评估IFN受体子单元 (RS) 和ISG表达.
西布洛特将分析JAK/STAT通路激活,用于ISRE活性的光酶测定,以及用于细胞活力和亡的WST-1/caspase测定.

主要成果:

通过RS,IFN暴露激活了BLCA细胞中的JAK/STAT通路.
I型和III型IFN显著增加了ISG表达,并在RT4和SW780细胞中诱导了亡.
IFN-β在激活JAK/STAT通路和调节由ISRE调节的细胞反应方面表现出最高的功效.

结论:

内在免疫系统的激活,包括IFN,可以增强免疫细胞透到瘤微环境 (TME).
这种免疫调节对TME的组成和抗瘤导向产生了积极的影响.
这些发现凸显了IFN基疗法在膀癌治疗中的潜力.

关键词:

巴西勒斯卡尔梅特 - 格埃林 (BCG)膀癌 (BLCA) 细胞干扰素 (IFN) 是一种干扰素.非肌肉侵入性膀癌 (NMIBC) 是一种非肌肉侵入性膀癌.

更多相关视频

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model

Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model

Published on: May 29, 2015

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.